Table 2.
Demographic information of included studies.
| Study | Risk Type | N Subjects |
N Female |
Mean Age |
IQ |
||||
|---|---|---|---|---|---|---|---|---|---|
| Risk | Non-Risk | Risk | Non-Risk | Risk | Non-Risk | Risk | Non-Risk | ||
| Acheson et al. (2014a) | FH | 28 | 24 | 19 | 16 | 23.6 | 24 | NA | NA |
| Acheson et al. (2014b) | FH | 72 | 32 | 37 | 14 | 12.9 | 12.9 | 96.5 | 102 |
| Cservenka et al. (2012) | FH | 19 | 16 | 6 | 8 | 14.01 | 14.18 | 110.16 | 111.25 |
| Heitzeg et al. (2010b) | FH | 20 & 21 | 20 | 17 | 9 | 19.15 | 19.2 | 109.51 | 112 |
| Mackiewicz Seghete et al. (2013) | FH | 18 | 16 | 7 | 8 | 14.52 | 14.18 | 112.67 | 112.69 |
| Norman et al. (2011) | PRO | 21 | 17 | 10 | 9 | 13.9 | 13.4 | NA | NA |
| Tervo-Clemmens et al. (2018) | PRO | 21 | 63 | 10 | 34 | 12.67 | 12.77 | 98.45 | 103.79 |
| Wetherill et al. (2013) | PRO | 20 & 20 | 20 | 18 | 9 | 13.4 | 13.3 | NA | NA |
| Cservenka et al. (2014) | FH | 19 | 17 | 10 | 7 | 14.92 | 14.69 | 110.84 | 113.29 |
| Hulvershorn et al. (2013) | FH | 19 | 18 | 5 | 7 | 12.2 | 11.9 | 98.2 | 111.8 |
| Peraza et al. (2015) | FH | 14 | 15 | 6 | 6 | 13.73 | 13.67 | 115.93 | 119.86 |
| Qiao et al. (2015) | FH | 11 | 7 | 4 | 3 | 12.7 | 13.6 | NA | NA |
| Cservenka and Nagel (2012) | FH | 18 | 13 | 6 | 5 | 14.18 | 14.24 | 110.56 | 111.46 |
| Hulvershorn et al. (2015) | FH | 23 | 27 | 13 | 9 | 12.3 | 11.9 | 96.5 | 111.2 |
| Morales et al. (2018) | PRO | NA | NA | NA | NA | NA | NA | NA | NA |
| Stice et al. (2013) | PRO | 25 | 80 | NA | NA | NA | NA | NA | NA |
| Stice and Yokum (2014) | FH | 26 | 26 | 14 | 13 | 14.7 | 14.9 | NA | NA |
| Ivanov et al. (2012) | FH | 10 | 10 | 1 | 1 | 10.33 | 10.75 | 89.62 | 101.18 |
| Dager et al. (2013) | FH | 10 & 11 | 25 & 19 | 12 | 24 | 19.38 | 19.3 | NA | NA |
| Dager et al. (2014) | PRO | 14 | 16 & 13 | 7 | 16 | 18.21 | 18.61 | NA | NA |
| Kareken et al. (2013) | FH | 22 | 18 | 10 | 7 | 22.7 | 23.7 | NA | NA |
| Nguyen-Louie et al. (2018) | FH | 23 | 28 | NA | NA | NA | NA | NA | NA |
| Totals/Weighted Means | 513 | 540 | 212 | 205 | 15.45 | 15.24 | 103.4 | 108.6 | |
Note, Risk Type: PRO, prospective predictions of substance use initiation or escalation; FH, family history of substance use disorder. NA, information not-available/not-reported. “&” denotes two groups/types reported in original study. In cases where two groups/types were presented, demographic information is a weighted mean based on group sizes.